Symptomatic Management of Chronic Stable Angina

Nicostar is generally used for the long-term symptomatic management of chronic stable angina pectoris, which is chest discomfort linked to insufficient blood flow to the heart muscle. The medication may be part of symptomatic management for conditions such as stable ischemic heart disease.

The medication is utilized in adults when stable angina is inadequately controlled by, or when patients have a known intolerance to, other antianginal therapies. It is often used in contexts involving recurrent or episodic manifestations, such as stable angina pectoris.

Managing Symptom Burden and Functional Stability

The therapeutic role involves supporting the management of the severity and occurrence of anginal pain that is typically triggered by exertion. This offers supportive relief in clinical settings marked by predictable symptom patterns, and may assist with managing the frequency of recurrent episodes of chest discomfort. By addressing symptoms that create noticeable physiological strain, the medication supports patients during symptomatic phases and may help with managing symptoms that interfere with daily functioning.

Quick Fact: Relief for Recurrent Chest Discomfort

Nicostar (Nicorandil) is indicated for use in adults with chronic stable angina pectoris whose condition is inadequately controlled by, or who have an intolerance to, first-line therapies. Use is not recommended for paediatric patients as safety and efficacy have not been established. Older adults are eligible for treatment, but the use of the lowest effective dose is recommended.

---

Contraindicated Populations

Nicostar is formally contraindicated in patients with:

• Shock, severe hypotension, or hypovolaemia (low blood volume).
• Severe left ventricular dysfunction with low filling pressure or acute pulmonary oedema.
• Concomitant use of Phosphodiesterase 5 (PDE5) inhibitors (e.g., sildenafil) or soluble guanylate cyclase (sGC) stimulators (e.g., riociguat).

---

Restricted and Conditional Use

• Pregnancy and Lactation: Use is not recommended unless considered essential by the physician.
• Comorbidities: Caution is advised in patients with a history of gastrointestinal ulcerations or diverticular disease, G6PD deficiency, or moderate to severe renal impairment when taking medicines that may increase potassium levels.

Interactions with other medicines and products

Official regulatory documents classify interactions with Nicostar (Nicorandil) based on the risk of severe hypotension and other systemic complications.

Contraindicated Combinations

Co-administration of Nicostar is strictly forbidden with medicinal products that enhance its hypotensive effects, resulting in a serious fall in blood pressure.

Classification	Interacting Medicines/Classes
CONTRAINDICATED	Phosphodiesterase 5 (PDE5) Inhibitors (e.g., sildenafil, tadalafil, vardenafil)
CONTRAINDICATED	Soluble Guanylate Cyclase (sGC) Stimulators (e.g., riociguat)

Other Clinically Significant Interactions

Caution is required when Nicostar is used with other agents that may lower blood pressure or increase the risk of specific gastrointestinal complications. Co-administration with other medicines that have a blood pressure lowering effect, such as antihypertensive agents, vasodilators, and tricyclic antidepressants, can result in an additive hypotensive effect.

Increased risk for severe gastrointestinal issues has been documented when Nicostar is combined with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including acetylsalicylic acid, or corticosteroids.

Caution is also advised in patients with moderate to severe renal impairment when used in combination with medicines that may increase potassium levels.

How Nicostar Works

Nicostar (nicorandil) exerts its effect through a unique dual mechanism that modulates vascular smooth muscle tone by influencing both ion channel dynamics and the nitric oxide signaling pathway. This approach facilitates modulation of vascular smooth muscle tone.

---

Dual K ATP Channel Opening and NO Donor Action

Nicostar acts as an opener of ATP-sensitive potassium ( K ATP) channels on the cell membrane, which causes an efflux of potassium ions. Simultaneously, the drug provides a nitrate-like action, releasing nitric oxide ( NO) that stimulates the guanylate cyclase enzyme pathway.

---

Modulation of Vascular Signaling

By opening K ATP channels, Nicostar induces cellular hyperpolarization. This ion flux limits the influx of calcium ions, which is a key requirement for muscle contraction. The NO-mediated signaling cascade increases levels of cyclic guanosine monophosphate ( cGMP). The combined molecular effects result in the dephosphorylation of myosin light chains, causing smooth muscle fiber relaxation.

---

Resulting Physiological Vasodilation

The activation of both the K ATP channel and the cGMP pathway leads to a dual- pathway vasodilation in both the peripheral and coronary vascular beds. This resulting physiological effect modulates systemic and coronary vascular resistance, thereby influencing myocardial oxygen supply and demand.

How Nicostar is Used (Nicorandil)

The administration of Nicorandil is guided by established protocols. These instructions specify the appropriate route, dosage, and frequency patterns for its use.

Official Administration Guidelines

Category	Instruction
Route of Administration	Primarily Oral (tablets) for long-term use; Intravenous (IV) injection is reserved for acute, clinically supervised settings.
Dosing Schedule	Therapy typically begins with 10 mg taken twice daily (bid), or 5 mg bid if a lower starting dose is required. The dosage should be titrated upwards based on response and tolerance, up to a maximum labeled dose of 40 mg twice daily.
Intake Conditions	Tablets must be swallowed whole with liquid and can be taken independently of food intake. Tablets possess a score line and may be divided into equal doses.
Population Rules	Older Adults have no special requirements, but the use of the lowest effective dose is advised. Use is not recommended for the paediatric population (under 18 years) due to insufficient data.

Connection to the Overall Use Protocol

These instructions establish a standardized, long-term administration protocol. The twice-daily frequency establishes a strict rhythm to support continuous management of the condition. Administration involves a systematic pathway for adjusting the dosage from the initial starting point to the maximum dose over the course of the long-term treatment. The tablets must be protected from moisture and kept in the original blister until the moment of intake.

Research evidence / Overview of studies

This section reviews the research evidence available for Nicorandil (the active substance in Nicostar). Studies have evaluated whether it was associated with changes in patient status, primarily in stable angina pectoris.

Results in Adults with Stable Angina Pectoris (Condition A)

Research has explored whether Nicorandil was associated with findings related to pain and inflammation in adults with stable angina. Some studies investigating this reported an observation of decreased measurements for angina episodes and pain intensity.

Study Type	Population	Study Focus / Primary Outcome Evaluated
RCT (Phase III)	Patients with stable angina	Investigated the relationship between the substance and symptom severity over specified treatment durations.
Large-scale Trial (IONA)	5,126 patients with stable angina	Reviewed whether Nicorandil, when added to standard treatment, was associated with a reduction in the composite endpoint of coronary heart disease death, non-fatal myocardial infarction, or unplanned hospitalization for cardiac chest pain.

Extended Applications

Studies have examined the data relating to Nicorandil use as an adjunct during percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). Research has explored whether it was associated with measured values relating to microvascular function and the incidence of post-PCI cardiac events.

Safety Profile and Use Parameters

Clinical trials have included patients with pre-existing conditions. Research has examined the safety profile of Nicorandil in various cardiac populations. Studies have also investigated the effects of treatment duration and whether continuing treatment for the full duration specified by clinical trials correlated with the incidence of relapse. Studies have compared the side-effect profile of Nicorandil to older generation treatments, such as long-acting nitrates.

Key Studies & References

1. Effect of nicorandil on coronary events and hospital admissions in patients with stable angina: the IONA study
2. Nicorandil: a review of its use in chronic stable angina pectoris and its microvascular effects in acute coronary syndrome

Common questions about Nicostar (FAQ)

Q: What is Nicostar and what is it used for?

A: Nicostar is a medicine whose active ingredient is nicorandil. It is classified as a vasodilator, which means it helps to widen blood vessels.

It is used to prevent and treat stable angina pectoris, which is a type of chest pain caused by the heart muscle not getting enough oxygen due to narrowed blood vessels.

Q: How does Nicostar work?

A: Nicostar works by having a dual mechanism of action:

• It acts as a nitrate-like vasodilator, which relaxes and widens the large blood vessels in the heart (coronary arteries) and the body.
• It activates specific potassium channels in the heart's blood vessel walls, which also causes them to relax and widen.

This combined action improves blood and oxygen supply to the heart muscle and reduces the heart's overall workload, which helps to reduce or prevent angina pain.

Q: What are the most common side effects of Nicostar?

A: Like all medicines, Nicostar can cause side effects, though not everyone gets them. The most common side effects are often experienced early in treatment and can include:

• Headache (very common, often improves with continued use)
• Dizziness
• Nausea or vomiting
• Flushing (reddening of the face, neck, and chest)

Less common, but important side effects can include low blood pressure (hypotension) or the development of ulcers, particularly in the mouth, eyes, or gastrointestinal tract.

Q: Can I take Nicostar with or without food?

A: Nicostar can generally be taken with or without food. You should swallow the tablet whole with a glass of water. It is important to take it exactly as prescribed by your doctor.

Q: What should I do if I miss a dose of Nicostar?

A: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and return to your regular dosing schedule. Do not take a double dose to make up for a missed one.

Q: What other medicines should not be taken with Nicostar?

A: Nicostar should not be taken with medicines used for erectile dysfunction, such as sildenafil or tadalafil, or with medicines like riociguat (used to treat high blood pressure in the lungs).

Combining these medicines with Nicostar can cause a dangerous and severe drop in blood pressure. Always inform your doctor or pharmacist about all other prescription and non-prescription medicines you are taking.

️ How to Store and Dispose of Nicostar?

To ensure Nicostar (Nicorandil) maintains its full efficacy, store it at room temperature, ideally between 20°C and 25°C (68°F and 77°F). Keep the medication in its original container and protect it from moisture and excessive heat. Do not store it in a bathroom or near a sink. Always ensure the container is tightly closed after use.

Keep all medications out of the sight and reach of children and pets.

Disposal Guidelines

Proper disposal is crucial for safety and environmental protection. Do not flush Nicostar down the toilet or pour it into a drain unless instructed by a healthcare professional or a drug take-back program. The best method for disposing of unused or expired Nicostar is through a drug take-back program. If a take-back program is unavailable, consult your local waste disposal company or pharmacy for guidance on proper household disposal.